C2N Diagnostics LLC, a St. Louis-based biotechnology firm that created a blood test designed to help doctors detect Alzheimer's disease, has added to its executive team with roles focused on commercialization and strategic partnerships.
C2N said this week it has hired Ozgur Sensoy as senior vice president of commercial operations and Daniel Connell as head of strategic alliances. The leadership additions come as C2N recently has brought on new funding and shared research results it says “demonstrate…
